CRISPR Therapeutics (CRSP) FY Conference June 09, 2025 03:20 PM ET Speaker0 Good afternoon. Thank you everyone for joining us in Salveen Richter, Biotechnology Analyst at Goldman Sachs. We're really pleased to have Sam Kulkarni, Doctor. Sam Kulkarni, CEO and Chairman of CRISPR here. Sam, to start, could you give us a brief overview of the company at this point, your strategy, your pipeline and really kind of the key focus areas headed into the half of the year? Speaker1 Yes. Thank you for having us and it's ...